Nachiketh Soodana‐Prakash
Papers
7
Total Citations
1,012
H-Index
5
About
Dr. Nachiketh Soodana‐Prakash is a leading urologic oncologist whose research centers on optimizing surgical outcomes for genitourinary cancers, with a particular focus on bladder and prostate cancer. He is best known for his pivotal role in the landmark RAZOR trial, the first multi-institutional randomized phase 3 study to demonstrate that robot-assisted radical cystectomy is non-inferior to open surgery for bladder cancer patients. This work, published in *The Lancet* and cited over 760 times, has fundamentally reshaped surgical practice. Dr. Soodana‐Prakash has further advanced this field by analyzing long-term oncologic outcomes and health-related quality of life from the RAZOR trial, providing crucial data that robotic approaches do not compromise survival while offering comparable patient well-being. His research also extends to renal cancer, examining trends in partial nephrectomy utilization, and to prostate cancer, where he investigates evolving risk classifications and the impact of West African genetic ancestry on high-grade disease. Through these contributions, Dr. Soodana‐Prakash has provided the highest level of evidence guiding the adoption of minimally invasive surgery in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5Kidney Autotransplantation: Between the Past and the Future29 citations · 2018
- 6
- 7